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Renal proximal tubular damage and repair are hallmarks of
acute kidney injury. As glycogen synthase kinase-3b (GSK3b)
is an important cellular regulator of survival and proliferation,
we determined its role during injury and recovery of proximal
tubules in a mercuric chloride–induced nephrotoxic model of
acute kidney injury. Renal proximal tubule–specific GSK3b
knockout mice exposed to mercuric chloride had improved
survival and renal function compared to wild-type mice.
Apoptosis, measured by TUNEL staining, Bax activation, and
caspase 3 cleavage, was reduced in the knockout mice. The
restoration of renal structure, function, and cell proliferation
was also accelerated in the GSK3b knockout mice. This
enhanced repair, evidenced by increased Ki-67 and BRDU
staining, along with increased cyclin D1 and c-myc levels, was
recapitulated by treatment of wild-type mice with the small-
molecule GSK3 inhibitor TDZD-8 following injury. This
confirmed that hastened repair in the knockout mice was not
merely due to lower initial injury levels. Thus, inhibition of
GSK3b prior to nephrotoxic insult protects from renal injury.
Such treatment after acute kidney injury may accelerate
repair and regeneration.
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Acute kidney injury (AKI) is characterized by an abrupt loss
of renal function caused by ischemia–reperfusion or ne-
phrotoxic insult and increases the risk of later chronic kidney
disease.1–4 AKI involves a complex series of events that leads
to tissue injury including endothelial and epithelial cell death,
intra-tubular obstruction, changes in local microvascular
blood flow, and inflammatory processes.5 The epithelial cells
of proximal tubules are most susceptible to injury, as they
have a high metabolic rate and greater ability to take up and
concentrate toxins from both the luminal and the basolateral
sides.6,7 However, these cells also have an amazing capacity to
regenerate.1,8 Glycogen synthase kinase-3 (GSK3) is a serine/
threonine protein kinase that is well positioned to coordinate
multiple signaling pathways that regulate various cellular
processes including gene transcription, translation, cytoske-
letal organization, cell cycle progression, and survival.9,10
GSK3 exists in two isoforms encoded by distinct genes, a
and b. As GSK3a and GSK3b isoforms share 98% sequence
homology in their kinase domains,11 no truly isoform-
specific GSK3b inhibitors have been developed yet.12,13
GSK3b is widely expressed in the kidneys,14–19 and recent
studies have identified a possible role for GSK3b in renal
tubular injury. Gene silencing of GSK3b in cultured proximal
tubular cells reduced ATP depletion–induced apoptosis.20
Further, inhibition using GSK3 isoform nonselective inhibi-
tors reduced injury in endotoxemia and ischemia–reperfu-
sion-induced AKI.20–22 As these studies used systemic
inhibition of GSK3 to examine renal injury, the specific role
of GSK3b in survival of the proximal tubules per se has
remained unclear. In addition, the role of GSK3b in repair
and regeneration of proximal tubules in AKI has not been
explored. GSK3 isoforms have a pivotal role in cell cycle
progression in embryonic stem cells and other cultured cell
types.10 Although the relative importance of GSK3a and
GSK3b isoforms in proliferation is not clear, targeted global
knockout (KO) of GSK3b in mice resulted in hyperprolifera-
tion of cardiomyocytes during embryonic development,
whereas mice with global KO of GSK3a appeared to be
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normal in this respect.23 In a recent study, Peng et al.24
reported that inhibition of GSK3 reduced migration of
cultured proximal tubule cells in a scratch wound healing
assay, suggesting suppression of wound healing in renal
tubular cells. This result potentially contradicts the observa-
tions that inhibition of GSK3 is generally protective and
reduces damage. Hence, in this study, we used proximal
tubule–specific GSK3b KO mice to examine the specific role
of GSK3b in tubular injury and repair in AKI.
We chose the widely used HgCl2-induced model of
AKI25–28 because mercury is a potent nephrotoxin, and its
uptake via luminal g-glutamyltranspeptidase (g-GT) and the
basolateral organic anion transporter system results in
preferential accumulation and cytotoxicity of proximal
tubules.25,29–34 Here, we report on the impact of selective
genetic and chemical inhibition of GSK3 on initial damage
and subsequent repair of renal proximal tubules in AKI.
RESULTS
Generating renal proximal tubule–specific GSK3b KO mice
To obtain renal proximal tubule–specific gene deletion of
GSK3b, we bred GSK3bloxp/loxp mice35 with g-GT-Creþ /þ
mice.36 Mice progeny exhibited the expected Mendelian ratio,
and histopathological examination revealed no renal ab-
normalities in the KO mice (GSK3bloxp/loxp, g-GT-Creþ /þ )
when compared with wild type (WT) (GSK3bloxp/loxp, g-GT-
Cre/). Western blot analysis of lysate from whole renal
cortex (Figure 1a) and isolated proximal tubules (Figure 1b)
showed significantly reduced levels of GSK3b expression in
the KO mice compared with WT mice. Immunohistochem-
ical staining with antibodies selective for GSK3b showed
significantly reduced levels of GSK3b in the proximal tubules
but not in other nephron segments of KO mice (Figure 1c).
Proximal tubule–specific KO of GSK3b reduces
HgCl2-induced mortality and tubular injury
When treated with 8.14 mg/kg body weight of HgCl2, a 10%
mortality rate was observed in both WT and KO groups
within 24 h (Figure 2). By days 2–3, the mortality rate further
increased to 40% in the WT group, whereas it remained
unchanged in the KO cohort, indicating that GSK3b gene
deletion in the proximal tubule reduced HgCl2-induced
mortality (Figure 2). Kidneys showed tubular dilatation,
cellular necrosis, and loss of brush border in both WT and KO
mice by day 2 after HgCl2 treatment (Figure 3a). Semiquanti-
tative injury score showed that on day 2 the injury score in the
KO mice was only half of that in WT mice (Figure 3b). The
injury score did not change significantly in WT mice by day 4
and remained 16-fold higher than baseline values on day 6. In
the KO mice, the injury score decreased by 1.8-fold on day 4
and attained baseline levels by day 6. Blood urea nitrogen
(BUN) levels increased by 7.8-fold in WT and 3.5-fold in the
KO group by day 2 after HgCl2 treatment compared with
baseline (20±6 vs. 155±15 mg/dl in WT and 25±7 vs.
87±18 mg/dl in KO). By days 4 and 6, BUN levels in the KO
mice were reduced by 42% and 60%, respectively, returning to
levels close to the baseline. In contrast, BUN levels remained
essentially unchanged in the WT group on day 4, followed by
a 40% decrease on day 6, but failed to reach baseline levels
even by day 8 (Figure 3c). Plasma creatinine levels showed a
similar pattern (Figure 3d).
Reduced apoptosis in the renal cortex of GSK3b KO mice
following HgCl2 treatment
To examine whether the reduced levels of injury in the KO
mice could be attributed to a decreased rate of apoptosis,
terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) assay was carried out. Within
24 h after HgCl2 treatment, 12% of nuclei were TUNEL
positive in the WT kidney compared with only 4% in
KO (Figure 4a and b). These apoptotic cells were mostly in
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Figure 1 |Reduced expression of glycogen synthase kinase-3b
(GSK3b) in renal proximal tubules of knockout (KO) mice.
Western blot analysis shows reduced GSK3b protein levels in
tissue lysate of GSK3bloxp/loxp, g-glutamyltranspeptidase (g-GT)-
Creþ /þ (KO) compared with GSK3bloxp/loxp, g-GT-Cre/ (wild
type (WT)) in (a) whole renal cortex and (b) acutely isolated
proximal tubules from renal cortex. (c) Immunohistochemical
staining shows reduced expression of GSK3b in proximal tubules
(PT) but not in the collecting ducts (CD) of KO mice (anti-GSK3b
antibody,  200 original magnification).
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Figure 2 |Knockout (KO) mice show higher survival rate
following HgCl2 treatment. Kaplan–Meier survival curve of wild-
type (WT) and KO mice injected with a single subcutaneous
injection of 8.14mg/kg body weight of HgCl2. *Po0.01, n¼ 20
per group.
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proximal tubules as shown by an immunoperoxidase-labeled
TUNEL assay (Supplementary Figure S1 online). This result
indicated that apoptosis was associated with tissue injury
early in HgCl2-induced AKI, and the rate of apoptosis was
reduced in KO mice.
To determine the mechanism underlying the antiapoptotic
effect of GSK3b gene deletion, we examined protein levels
of pro-apoptotic- activated Bax, cleaved caspase 3, and an
antiapoptotic factor Bcl 2. Although a time-dependent
increase in activated Bax levels was observed in both WT
and KO mice, the levels were significantly lower in KO mice
(Figure 4c). Activated Bax levels in the KO mice were lower
by 2- and 2.8-fold, respectively, on days 1 and 2 when
compared with WT mice (Figure 4d). Total Bax levels showed
no change. Cleaved caspase 3 levels peaked on day 1,
increasing by fivefold compared with day 0 levels. Compared
with WT mice, in KO mice cleaved caspase 3 levels were
five- and twofold lower on days 1 and 2, respectively
(Figure 4c and e). In the WT group, Bcl 2 levels were reduced
by 20% and 40%, respectively, by days 1 and 2, compared
with day 0. In the KO mice, no significant difference was
observed (Figure 4c and f). These data demonstrate that the
KO mice were protected from the apoptosis caused by HgCl2.
Accelerated cell proliferation in renal proximal tubules
of KO mice
We next determined whether GSK3b gene deletion in
proximal tubule cells alters their proliferative response after
injury. Ki-67 nuclear staining, a proliferative marker, was
higher by 2-fold on day 2 and 3.5-fold on day 4 in the KO
group compared with the WT group (500-fold more than
baseline) (Figure 5a and b). 5-bromo-20-deoxyuridine
(BRDU)-positive nuclei were also 2.5-fold higher in the KO
kidney on day 4 compared with WT (Figure 5c and d). Both
Ki-67 and BRDU staining decreased in KO kidneys after day
4, consistent with the improved renal function and decreased
histopathology injury data. Triple immunofluorescence
staining of kidneys on day 4 showed that the dividing cells,
indicated by proliferating cell nuclear antigen staining, were
more abundant in the KO mice, and were primarily located
in the proximal tubule (stained with Lotus tetragonolobus
agglutinin) (Figure 5e).
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Figure 3 |Proximal tubule–specific glycogen synthase kinase-3b (GSK3b) gene deletion reduced HgCl2-induced renal injury.
(a) Tubular injury is manifest as necrotic tubules (*), flattened epithelium (arrows), and loss of nuclei (arrows), and was less severe in
knockout (KO) compared with wild type (WT) at all-time points (hematoxylin and eosin,  200 original magnification). (b) Injury score of
renal tissue sections. **Po0.001, n¼ 5 per group. (c) Blood urea nitrogen (BUN) and (d) serum creatinine levels are lower in KO mice.
**Po0.001, n¼ 21 per group.
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To examine the mechanism for the higher rate of
proliferation in the KO mice, protein levels of the pro-
proliferative factors, cyclin D1, c-myc, and b-catenin, known
to be regulated by GSK3b were measured. Cyclin D1 and
c-myc levels in the kidney cortex were markedly upregulated
in KO mice compared with WT mice, especially on days 1–4
(Figure 6a). Interestingly, cyclin D1 levels decreased by day 6
in the KO mice, whereas in the WT mice the highest cyclin D1
levels were observed on days 6 and 8 (Figure 6b). c-myc levels
were significantly higher in KO mice on days 3, 4, and 6
compared with that in WT mice (Figure 6c). b-Catenin levels
did not differ significantly between the WT and KO groups.
These results indicated an accelerated rate of proliferation in
KO mice when compared with WT mice. Examination of renal
fibrosis by Sirius red staining, a marker of collagen, revealed
no significant difference between the WT and KO mice 8 days
after HgCl2 treatment, although it is possible that fibrosis
occurs after a longer period of time (Supplementary data).
Paired study shows that GSK3b inhibition accelerates
proliferation
To probe further the role of GSK3b in regeneration following
AKI, we tested the effect of TDZD-8, a small-molecule
inhibitor of GSK3.37,38 In this study, TDZD-8 treatment was
carried out after onset of injury in WT mice. WT mice were
first administered 6.3 mg/kg of HgCl2. On day 2 (48 h after
HgCl2), BUN levels were measured and mice with approxi-
mately 82±2 mg/dl were separated into two groups. One
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Figure 4 |HgCl2-induced apoptosis is reduced in knockout (KO) mice. (a) Terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling (TUNEL) nuclear staining in renal cortex 24 h after HgCl2 treatment and (b) quantification, which shows reduced TUNEL-positive
nuclei in the KO group (n¼ 5 per group). (c) Cleaved caspase 3 and activated Bax levels are lower by western blot in KO kidney compared
with wild type (WT) (d, e, f). **Po0.001, ***Po0.0001. (d, e, f) Based on two time-course studies. DAPI, 4,6-diamidino-2-phenylindole.
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group was administered vehicle and the other TDZD-8 (1
and 0.5 mg/kg, respectively, on days 2 and 3 after HgCl2
treatment). In the TDZD-8-treated group, BUN levels
decreased significantly compared with the vehicle-treated
group (vehicle, 72±9 vs. TDZD-8, 51±6 mg/dl on day 4,
n¼ 9 and vehicle, 51±8 vs. TDZD-8, 30±7 mg/dl on day 6,
n¼ 6) (Figure 7a). TDZD-8-treated mice also showed 40%
and 36% lower kidney injury scores compared with vehicle-
treated mice on days 4 and 6, respectively (Figure 7b and c),
indicating that inhibition of GSK3 accelerated regeneration.
Further, protein levels of cyclin D1, c-myc, and b-catenin
were significantly higher on days 3 and 4 in the TDZD-8-
treated compared with the vehicle-treated mice (Figure 8a).
By day 4, the number of BRDU-positive nuclei in TDZD-8-
treated mice was almost double when compared with vehicle-
treated mice (Figure 8b and c). Similarly, Ki-67 staining was
more than double in the TDZD-8-treated mice, compared
with the vehicle-treated mice on day 4 (Figure 8d and e).
Sirius red staining, on tissue sections, 8 days after HgCl2
treatment revealed no significant change in fibrosis between
the two groups at this time point (Supplementary data).
Regulation of renal GSK3b activity in response to HgCl2
treatment
We next examined whether GSK3b activity was regulated in
HgCl2-induced AKI. Protein levels of pGSK3b, the inhibited
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Figure 5 |Proliferation is accelerated in knockout (KO) kidneys. Immunohistochemical staining and quantification for (a, b) Ki-67 and
(c, d) BRDU show more proliferating cells in KO kidneys. **Po0.001. ***Po0.0001, n¼ 5 per group,  200 original magnification.
Immunofluorescence staining for proliferating cell nuclear antigen (PCNA) and Lotus tetragonolobus agglutinin (LTA) shows more dividing
cells in proximal tubule cells of KO mice on day 4 after HgCl2 treatment (e);  400 original magnification. DAPI, 4,6-diamidino-2-
phenylindole, WT, wild type.
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form of GSK3b phosphorylated at serine 9, decreased to
undetectable levels 6 h after HgCl2 injection, gradually
increasing by 16 h (Figure 9a). By 32 h, pGSK3b levels
increased above baseline levels and remained high for 5 days.
Protein levels of b-catenin, a negatively regulated substrate
of GSK3, also increased by 48 h, consistent with the GSK3
inhibition. These data indicated that, following HgCl2
treatment, GSK3b (and likely also GSK3a) was initially
activated and then subsequently inhibited.
DISCUSSION
Our studies demonstrate that GSK3b activity in the renal
proximal tubules modulates injury and repair in HgCl2-induced
AKI. Proximal tubule–specific KO of GSK3b improved survival
in HgCl2-treated mice by reducing nephrotoxicity and injury, as
well as accelerating cell proliferation and repair. These studies
show the broader benefits of GSK3b gene deletion or inhibition
on reducing injury and, more importantly, on repopulating
renal proximal tubules after AKI.
Renal tubular injury is a distinctive feature of AKI,
characterized by apoptosis and necrosis of renal tubules. The
extent of injury in our study was similar to previously
reported in vivo patterns of HgCl2-induced nephrotoxicity,
27,28
insofar as the onset of toxic effects was very rapid and injury
was accompanied by apoptosis. Compared with WT mice, the
KO mice had better renal function following HgCl2 treatment
with lower BUN and plasma creatinine levels. This was linked
to less severe injury and accelerated repair observed in KO
mice. The reduced injury itself could be at least partially due
to a reduced rate of apoptosis in the KO mice.
GSK3b is known to regulate the intrinsic mitochondrial
apoptotic pathway.39 Bax, a pro-apoptotic protein that is
constitutively expressed in the cell, is activated by phosphor-
ylation by GSK3b.40 The activated Bax oligomerizes with the
mitochondrial outer membranes and forms pores leading to
the release of cytochrome c and other pro-apoptotic factors,
which in turn activate caspase-dependent or -independent
pathways.5,41–43 In our study, activated Bax levels and cleaved
caspase 3 levels were lower in the KO mice compared with
WT mice. Similarly, Bcl 2, an antiapoptotic protein, remained
unchanged in KO mice, whereas it was reduced in the WT
mice following HgCl2 treatment. Bcl 2 is cleaved/degraded by
caspase 3 during apoptosis, which in turn leads to
mitochondrial pore formation.44 Earlier studies demon-
strated that systemic GSK3 inhibition could reduce apoptosis
associated with endotoxemia21,22 and ischemia–reperfusion
models of AKI.20 Although consistent with these studies, our
results clearly demonstrated that gene deletion of GSK3b in
the proximal tubule per se reduces apoptosis and renal injury
and improves survival after AKI.
GSK3b is constitutively active in resting cells and under-
goes a rapid and transient inhibition in response to a number
of external signals. GSK3b activity increased within 6 h of
HgCl2 treatment, which coincided with the increased levels of
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apoptosis and injury seen in WT mice (Figure 8). These
results are consistent with similar findings in a rat model of
ischemia–reperfusion-induced AKI.20 Surprisingly, in our
study, GSK3b activity was reduced to below pre-HgCl2
treatment levels by 32 h and stayed low for 5 days. This
period of time (2–5 days after HgCl2 treatment) coincides
with a period of active cell proliferation and recovery in WT
mice, suggesting that suppression of renal GSK3b activity
could be a natural mechanism employed by renal tubules
undergoing regeneration following injury. Hence, it could be
possible that in the WT mouse kidney GSK3 is normally
inhibited to some extent by the phosphatidylinositol 3
kinase-AKT, protein kinase A, epidermal growth factor
receptor, and Wnt signaling pathways,45–48 which are known
to be important for cell proliferation and tissue repair.28,49–52
This response, however, might not be adequate to prevent
severe AKI and mortality. Our findings demonstrate that
proximal tubule–specific gene KO of GSK3b or the use of a
GSK3 inhibitor further significantly protected against injury
and accelerated the repair process.
A rapid proliferative response leading to the restoration of
nephron structure and function is very important, because
episodes of AKI are not always fully reversible and may lead
to chronic kidney disease. An interesting observation was that
repair occurred at a linear rate in the WT kidney, but at an
exponential rate in the KO kidney. On the basis of injury
scores, BUN/creatinine levels and cell proliferation, the phase
of renal repair began on day 2 and peaked on day 4 in KO
mice, whereas it started later in WT mice at days 4–6 after
initial injury. A paired study using similarly injured WT mice
showed that TDZD-8 treatment improved recovery of renal
structure and function and the rate of proliferation compared
with vehicle-treated mice, thus demonstrating that the
accelerated rate of repair in KO mice could not be attributed
to reduced levels of initial renal injury alone. Cyclin D1,
c-myc, and b-catenin are pro-proliferative factors and also
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substrates of GSK3b. Phosphorylation of cyclin D1, c-myc,
and b-catenin by GSK3b destabilizes them, leading to
ubiquitination and degradation.48,53,54 We found an acceler-
ated rate of increase in cyclin D1 and c-myc accumulation in
the GSK3b KO mice compared with the WT mice. This was
confirmed in studies using TDZD-8. Although b-catenin
levels were significantly higher in the TDZD-8-treated mice
than in the vehicle-treated mice, the KO mice did not show
such a change. Past studies have suggested that gene deletion
of at least three of the four alleles of both isoforms of GSK3a
versus b are required to show an appreciable change in b-
catenin levels.55 It could also be possible that administration
of HgCl2 by itself can increase b-catenin accumulation by
activating Wnt signaling.
Our observations on the rapid regenerative response in
GSK3b-inactivated renal proximal tubules could be important
in light of the current theory that it is the surviving renal
tubular epithelial cells that proliferate and repopulate tubules in
AKI.8 In WT embryonic stem cells, GSK3 inhibition has been
suggested to help in maintaining self-renewal and pluripo-
tency,56,57 and the inhibition of GSK3 has been reported to
enhance repopulation of the bone marrow by hematopoietic
stem cells.58 Hence, inhibition of GSK3b could be a key switch
that turns on cell proliferation and regeneration of renal
proximal tubules in AKI, thus warranting further studies.
In summary, GSK3b mediates injury and repair in HgCl2-
induced AKI. Although kidneys appear to have an innate
ability to suppress GSK3b activity in order to reduce injury
and promote regeneration of tubular cells, it is not sufficient
to protect mice from a high rate of mortality under condi-
tions of severe injury. Proximal tubule–specific KO of GSK3b
not only reduced tubular injury but also accelerated tubular
regeneration. Our study also showed that the mechanism of
GSK3b protection is specific to the kidney, as opposed to being
a systemic effect that could have indirectly ameliorated organ
damage. Thus, GSK3b could be a major regulator of recovery
from acute toxic kidney injury. This is clinically relevant as it
provides a possible treatment option to accelerate recovery
of established AKI. Thus, these findings have potential
therapeutic application for a broad range of kidney diseases.
MATERIALS AND METHODS
Generating KO mice
GSK3bloxp/loxp mice were bred with transgenic mice in which Cre
expression was driven by a promoter fragment of g-GT, expressed in
the proximal tubule.36 Mice were on a pure C57/BL6J background.
Genotype was determined by PCR using tail DNA and primers
described earlier.17,36 Proximal tubules were isolated from WT and
KO mice renal cortex by collagenase digestion, followed by percoll
gradient high-speed centrifugation.59,60
AKI studies
Female WT and KO mouse littermates, 10 weeks old and weighing
24–25 g, were injected once subcutaneously with HgCl2 at a
nephrotoxic dose of 8.16 mg/kg body weight.27 Mice were killed to
examine renal morphology and protein expression, and blood
plasma was collected for BUN and creatinine measurements. For
measurement of BRDU incorporation, mice received an injection 2 h
before killing. In a substudy (Figure 7), only WT mice were injected
with 6.3 mg/kg of body weight of HgCl2. Plasma BUN levels were
measured on day 2 and mice with comparable levels of BUN were
separated into two groups (n¼ 12 in each group). One group
received two intraperitoneal injections of an ATP noncompetitive
GSK3 inhibitor, TDZD-8 dissolved in 75% dimethylsulphoxide
(1 mg/kg on day 2 and 500 mg/kg on day 3), and the other group
received vehicle. All experiments were conducted in accordance with
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health (Bethesda, MD) and were approved by
the IACUC committee of Vanderbilt University.
BUN and creatinine measurements
BUN levels were measured using a QuantiChrom Urea Assay Kit
from BioAssay Systems, Hayward, CA. Creatinine levels were
measured using high-performance liquid chromatography at the
Vanderbilt Hormone Assay Core.
Western blot analysis
Protein (20mg) was loaded on 12 or 4–20% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis mini-gels and immunoblotting
was carried out as described earlier.17 Monoclonal antibody for
GSK3b (BD-Transduction Laboratories, San Jose, CA) and poly-
clonal antibodies for pGSK3b, b-actin, cleaved caspase 3, Bax (Cell
Signaling, Danvers, MA), and c-myc (Santa Cruz Biotechnology,
Santa Cruz, CA) were used.
Immunohistochemistry and immunofluorescence
Kidneys were collected at the time of killing and a cross-section was
immediately fixed in 4% paraformaldehyde at 4 1C overnight.
Samples were dehydrated in a graded alcohol series and embedded
in paraffin for histological analysis. To unmask antigens, 5-mm sections
were boiled in Target Retrieval solution (Dako, Carpinteria, CA).
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Figure 9 |Renal glycogen synthase kinase-3b (GSK3b) activity
changes in response to HgCl2 treatment. Western blot analysis
of tissue lysates from whole renal cortex of wild-type (WT)
mice injected once with 8.14mg/kg of HgCl2. (a) Inactive
phosphorylated GSK3b levels initially decreased within 6 h
after HgCl2 treatment and (b) increased to above baseline by
24 h. b-Catenin levels also increased on days 2–5.
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Polyclonal antibodies for GSK3b (Santa Cruz Biotechnology), Ki-67,
and BRDU (Cell Signaling) were used. LTL (Vector Laboratories,
Burlingame, CA), proliferating cell nuclear antigen (Dako), and
secondary antibody (Jackson ImmunoResearch Laboratories) con-
jugated to Cy3 were used. Ki-67-, BRDU-, and proliferating cell
nuclear antigen-positive nuclei and total nuclei were counted
manually at 20 , in 20 high-power fields for each kidney sample,
and an average percent positivity per high-power field was calculated
per kidney. Negative controls without primary antibody showed no
staining. Images were captured with a Nikon Eclipse E600 microscope
and a Nikon DXM1200 digital camera (Melville, NY). All assess-
ments were blinded to the treatment protocols.
TUNEL assay
TUNEL assay was performed to evaluate apoptosis using an In situ
Cell Death Detection Kit (Roche Applied Science, Indianapolis, IN).
In brief, 4-mm renal sections were exposed to a TUNEL reaction
mixture containing terminal deoxynucleotidyl transferase and
nucleotides, including tetramethylrhodamine-labeled dUTP. Total
and TUNEL-positive nuclei were counted as described for
proliferating cell nuclear antigen.
Tubule injury and fibrosis measurements
Tubular injury score was determined by assessing hematoxylin and
eosin–stained paraffin sections. Loss of brush border, tubular
dilation, cast formation, cell lysis, vacuolization, and sloughing
were scored on a scale of 0–4, where 0¼ no injury; 1¼ 5–25%;
2¼ 25–50%; 3¼ 50–75%; and 4¼475% tubules having necrosis,
dilatation, or cell swelling. The observer was unaware of the protocol
assignments of the mice. Fibrosis was measured by morphometric
analysis of collagen fibril by Sirius red staining. Deparaffinized
sections were stained with 0.1% picrosirius red.61
Statistical analysis
Comparisons between WT and KO mice or TDZD-8-treated and
vehicle-treated mice were analyzed by the unpaired Student’s t-test.
Comparisons of multiple points were made using analysis of
variance with the Bonferroni correction. Po0.05 was taken as
significant. Data are expressed as means±s.e.m.
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Figure S3. Sirius red staining of kidneys of WT mice treated with
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